Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Altium Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $283 Million distributed in 79 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vera Therapeutics, Inc. with a value of $30.2M, Adma Biologics, Inc. with a value of $27.2M, Sarepta Therapeutics, Inc. with a value of $21.2M, Edwards Lifesciences Corp with a value of $14.6M, and Xenon Pharmaceuticals Inc. with a value of $14.2M.

Examining the 13F form we can see an increase of $95.7M in the current position value, from $188M to 283M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $283 Million
Healthcare: $278 Million
Consumer Cyclical: $3.99 Million
Industrials: $102,000
Financial Services: $2,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.15B
$30.2 Million 10.66% of portfolio
684,000
Q3 2024 Reduced 4.2%
$3.42B
$27.2 Million 9.59% of portfolio
1,360,000
Q3 2024 Reduced 9.93%
$10.4B
$21.2 Million 7.49% of portfolio
170,000
Q3 2024 Added 107.57%
$46.3B
$14.6 Million 5.17% of portfolio
222,000
Q3 2024 New
$2.41B
$14.2 Million 5.01% of portfolio
360,600
Q2 2024 Added 3.62%
$7.88B
$11.3 Million 3.97% of portfolio
154,000
Q3 2024 Reduced 20.21%
$7.18B
$10 Million 3.54% of portfolio
77,000
Q3 2024 New
$9.54B
$9.49 Million 3.35% of portfolio
130,000
Q3 2024 Reduced 31.58%
$170M
$8.4 Million 2.96% of portfolio
1,700,000
Q3 2024 Added 46.25%
$5.59B
$8.39 Million 2.96% of portfolio
85,000
Q3 2024 New
$166M
$8.24 Million 2.91% of portfolio
1,700,000
Q2 2024 New
$5.13B
$8.22 Million 2.9% of portfolio
72,000
Q3 2024 New
$3.24B
$7.98 Million 2.81% of portfolio
126,000
Q3 2024 Added 3.28%
$2.19B
$7.65 Million 2.7% of portfolio
385,000
Q3 2024 Reduced 23.0%
$2.06B
$6.87 Million 2.42% of portfolio
355,000
Q3 2024 New
$368M
$6.68 Million 2.36% of portfolio
1,575,000
Q2 2024 Added 17.98%
$611M
$5.75 Million 2.03% of portfolio
355,000
Q3 2024 New
$971M
$5.66 Million 2.0% of portfolio
131,000
Q3 2024 New
$930M
$5.54 Million 1.95% of portfolio
112,000
Q3 2024 New
$3.89B
$5.21 Million 1.84% of portfolio
58,000
Q3 2024 Added 16.0%
$40M
$5.04 Million 1.78% of portfolio
7,415,413
Q2 2024 Reduced 3.04%
$174M
$4.54 Million 1.6% of portfolio
693,000
Q2 2024 Reduced 0.29%
$318M
$4.33 Million 1.53% of portfolio
285,000
Q3 2024 New
$229M
$4.14 Million 1.46% of portfolio
500,000
Q3 2024 New
$897M
$3.99 Million 1.41% of portfolio
1,270,000
Q3 2024 Added 1.58%
$439M
$4.01 Million 1.41% of portfolio
69,000
Q3 2024 New
$325M
$3.64 Million 1.28% of portfolio
355,000
Q3 2024 Reduced 12.35%
$2.67B
$2.87 Million 1.01% of portfolio
68,000
Q3 2024 New
$220M
$2.75 Million 0.97% of portfolio
330,000
Q3 2024 New
$167M
$2.33 Million 0.82% of portfolio
2,350,000
Q3 2024 New
$1.93B
$2.02 Million 0.71% of portfolio
40,000
Q3 2024 Reduced 65.22%
$436M
$1.93 Million 0.68% of portfolio
85,000
Q3 2024 New
$52.1M
$1.56 Million 0.55% of portfolio
2,028,534
Q3 2024 Reduced 10.9%
$1.43B
$1.51 Million 0.53% of portfolio
54,000
Q3 2024 New
$71.9M
$1.08 Million 0.38% of portfolio
915,000
Q3 2024 New
$23.6M
$802,000 0.28% of portfolio
238,920
Q3 2024 New
$7.4M
$763,000 0.27% of portfolio
545,000
Q3 2024 New
$0
$726,000 0.26% of portfolio
581,395
Q3 2024 New
$54M
$668,000 0.24% of portfolio
440,000
Q3 2024 Reduced 56.54%
$51.1M
$614,000 0.22% of portfolio
740,000
Q2 2023 Added 46.31%
$10.2M
$603,000 0.21% of portfolio
1,473,000
Q3 2024 New
$14.6M
$102,000 0.04% of portfolio
2,057,494
Q3 2024 New
$0
$99,000 0.03% of portfolio
225,000
Q4 2021 New
$0
$18,000 0.01% of portfolio
270,000
Q4 2021 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$0
$0 0.0% of portfolio
82,233
Q3 2021 New
$0
$0 0.0% of portfolio
18,823
Q4 2022 Reduced 98.0%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 39.24%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 79
  • Current Value $283 Million
  • Prior Value $188 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 31 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email